Enanta Pharmaceuticals (ENTA) Other Non Operating Income (2012 - 2022)
Enanta Pharmaceuticals' (ENTA) quarterly Other Non Operating Income came in at -$942000.0 in Q3 2022, up 43.29% YoY from -$657421.0 in Q3 2021, and down 339.69% on a QoQ basis from $393000.0 in Q2 2022.
Enanta Pharmaceuticals (ENTA) Other Non Operating Income (2012 - 2022) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 11 years of Other Non Operating Income data on file, last reported at -$942000.0 in Q3 2022.
- Quarterly Other Non Operating Income rose 43.29% year-over-year to -$942000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$36000.0 (changed N/A YoY) and the FY2020 annual result came in at $1.7 million, up 373.85% from the prior year.
- Other Non Operating Income slipped to -$942000.0 in Q3 2022, from $393000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.4 million in Q2 2019 to a low of -$7.2 million in Q3 2019.
- A 5-year average of -$205647.1 and a median of $258000.0 in 2021 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 24050.0% in 2019, down 1753.11% in 2019.
- Tracing ENTA's Other Non Operating Income over 5 years: stood at -$386000.0 in 2018, then surged by 637.82% to $2.1 million in 2019, then tumbled by 67.39% to $677000.0 in 2020, then slumped by 61.89% to $258000.0 in 2021, then slumped by 465.12% to -$942000.0 in 2022.
- The last three Other Non Operating Income figures came in at -$942000.0 (Q3 2022), $393000.0 (Q2 2022), and $255000.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -942,000.00 |
| Jun 30, 2022 | 393,000.00 |
| Mar 31, 2022 | 255,000.00 |
| Dec 31, 2021 | 258,000.00 |
| Sep 30, 2021 | -1.66 Mn |
| Jun 30, 2021 | 439,000.00 |
| Mar 31, 2021 | 545,000.00 |
| Dec 31, 2020 | 677,000.00 |
| Sep 30, 2020 | -3.81 Mn |
| Jun 30, 2020 | 1.45 Mn |
| Mar 31, 2020 | 1.95 Mn |
| Dec 31, 2019 | 2.08 Mn |
| Sep 30, 2019 | -7.15 Mn |
| Jun 30, 2019 | 2.42 Mn |
| Sep 30, 2018 | -386,000.00 |
| Jun 30, 2018 | 10,000.00 |
| Mar 31, 2018 | -11,000.00 |
| Sep 30, 2017 | 660,000.00 |
| Jun 30, 2017 | 600,000.00 |
| Mar 31, 2017 | 549,000.00 |